Mycophenolate mofetil therapy for lupus nephritis refractory to intravenous cyclophosphamide

被引：117
|
作者：
Glicklich, D [1 ]
Acharya, A [1 ]
机构：
[1] Montefiore Med Ctr, Albert Einstein Coll Med, Dept Med, Div Renal, Bronx, NY 10467 USA
来源：
AMERICAN JOURNAL OF KIDNEY DISEASES | 1998年 / 32卷 / 02期
关键词：
lupus nephritis; cyclophosphamide; mycophenolate mofetil;
D O I：
10.1053/ajkd.1998.v32.pm9708620
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
intravenous (IV) cyclophosphamide has been the treatment of choice for diffuse proliferative glomerulonephritis (DPGN) in patients with systemic lupus erythematosus (SLE), However, there is little guidance in the medical literature about what to do when this therapy fails. Mycophenolate mofetil (MMF), a new immunosuppressive agent, has been used successfully in patients with solid organ transplants and rheumatoid arthritis. We report two patients with diffuse proliferative glomerulonephritis who responded favorably to MMF therapy after IV cyclophosphamide failed. (C) 1998 by the National Kidney Foundation, Inc.
引用
收藏
页码：318 / 322
页数：5
相关论文
共 50 条
  • [11] Induction therapy for active lupus nephritis: mycophenolate mofetil is superior to cyclophosphamide
    Jennifer R Elliott
    Susan Manzi
    [J]. Nature Clinical Practice Rheumatology, 2006, 2 : 354 - 355
  • [12] Induction therapy for active lupus nephritis: mycophenolate mofetil is superior to cyclophosphamide
    Elliott, Jennifer R.
    Manzi, Susan
    [J]. NATURE CLINICAL PRACTICE RHEUMATOLOGY, 2006, 2 (07): : 354 - 355
  • [13] Mycophenolate mofetil for treatment of refractory lupus nephritis
    Johnson, DW
    [J]. INTERNAL MEDICINE JOURNAL, 2001, 31 (05) : 312 - 312
  • [14] Efficacy and Safety of Mycophenolate Mofetil Versus Intravenous Pulse Cyclophosphamide as Induction Therapy in Proliferative Lupus Nephritis
    Gadakchi, Leyla
    Hajialilo, Mehrzad
    Nakhjavani, Mohammad-Reza
    Azar, Sima Abedi
    Kolahi, Sousan
    Gojazadeh, Morteza
    Ebrahimi, Ali-asghar
    Mahdavi, Aida Malek
    Noshad, Hamid
    Khabbazi, Alireza
    [J]. IRANIAN JOURNAL OF KIDNEY DISEASES, 2018, 12 (05) : 288 - 292
  • [15] MYCOPHENOLATE MOFETIL IN THE TREATMENT OF REFRACTORY LUPUS NEPHRITIS
    Tan, C. H.
    Vathsala, A.
    Chiang, G. S. C.
    Howe, H. S.
    [J]. NEPHROLOGY, 2005, 10 : A171 - A171
  • [16] Is mycophenolate mofetil superior to pulse intravenous cyclophosphamide for induction therapy of proliferative lupus nephritis in Egyptian patients?
    Eid M. El-Shafey
    Said H. Abdou
    Mohamed M. Shareef
    [J]. Clinical and Experimental Nephrology, 2010, 14 : 214 - 221
  • [17] Is mycophenolate mofetil superior to pulse intravenous cyclophosphamide for induction therapy of proliferative lupus nephritis in Egyptian patients?
    El-Shafey, Eid M.
    Abdou, Said H.
    Shareef, Mohamed M.
    [J]. CLINICAL AND EXPERIMENTAL NEPHROLOGY, 2010, 14 (03) : 214 - 221
  • [18] Mizoribine versus mycophenolate mofetil or intravenous cyclophosphamide for induction treatment of active lupus nephritis
    Feng Xuebing
    Gu Fei
    Chen Weiwei
    Liu Yan
    Wei Hua
    Liu Lin
    Yin Songlou
    Da Zhanyun
    Sun Lingyun
    [J]. CHINESE MEDICAL JOURNAL, 2014, 127 (21) : 3718 - 3723
  • [19] Mizoribine versus mycophenolate mofetil or intravenous cyclophosphamide for induction treatment of active lupus nephritis
    Feng Xuebing
    Gu Fei
    Chen Weiwei
    Liu Yan
    Wei Hua
    Liu Lin
    Yin Songlou
    Da Zhanyun
    Sun Lingyun
    [J]. 中华医学杂志(英文版), 2014, (21) : 3718 - 3723
  • [20] Mycophenolate mofetil or tacrolimus compared with intravenous cyclophosphamide in the induction treatment for active lupus nephritis
    Li, Xiao
    Ren, Hong
    Zhang, Qianying
    Zhang, Wen
    Wu, Xiaojing
    Xu, Yaowen
    Shen, Pingyan
    Chen, Nan
    [J]. NEPHROLOGY DIALYSIS TRANSPLANTATION, 2012, 27 (04) : 1467 - 1472
12345